Osteoprotegerin/bone morphogenetic protein 2 combining with collagen sponges on tendon-bone healing in rabbits

J Bone Miner Metab. 2020 Jul;38(4):432-441. doi: 10.1007/s00774-019-01078-w. Epub 2020 Jan 24.

Abstract

Introduction: The aim was to investigate the effect of collagen sponges (CS) as a delivery device for osteoprotegerin (OPG)/bone morphogenetic protein 2 (BMP-2) and support matrix on the tendon-bone healing after anterior crusicate ligament (ACL) reconstruction in modeled rabbits.

Materials and methods: Sixty New Zealand white rabbits were randomly divided into four groups based on treatments they received at the tendon-bone interface after left knee ACL reconstruction: the control group, OPG/BMP-2, CS, and OPG/BMP-2/CS combination. At 4, 8 and 12 weeks post-surgery, five rabbits from each group were euthanized to examine the tendon-bone healing. Levels of OPG and BMP-2 in synovial fluid, the bone tunnel enlargement value, the histomorphological typing of tendon-bone interface, and the bone tunnel area of the tendon-bone interface were compared among different treatments.

Results: The OPG/BMP-2/CS combination treatment group had the highest levels of OPG and BMP-2 in synovial fluid (both P < 0.05), the greatest number of Sharpey-like collagen fibers at all test points (P < 0.05), the most fibrocartilage enthesis on week 12, the greatest bone tunnel area (P < 0.05), and the greatest decrease in bone tunnel enlargement on week 12 (P < 0.05). Histomorphological typing of tendon-bone interface of all groups showed changes varying from tendon-bone separation to firm healing, and the change was most significant in the OPG/BMP-2/CS combination treatment group.

Conclusion: CS treatment alone serves as a fixing support, and CS combining with growth factors OPG/BMP-2 ensures slow and stable release of OPG/BMP-2, significantly improves the tendon-bone healing in the rabbit ACL model.

Keywords: Anterior cruciate ligament; Bone morphogenetic protein 2; Bone tunnel enlargement value; Collagen sponges; Osteoprotegerin.

MeSH terms

  • Animals
  • Anterior Cruciate Ligament / drug effects
  • Anterior Cruciate Ligament / pathology
  • Bone Morphogenetic Protein 2 / pharmacology*
  • Bone and Bones / drug effects
  • Bone and Bones / pathology*
  • Collagen / pharmacology*
  • Female
  • Male
  • Osteoprotegerin / pharmacology*
  • Rabbits
  • Synovial Fluid / metabolism
  • Tendons / drug effects
  • Tendons / pathology*
  • Tendons / surgery
  • Wound Healing / drug effects*

Substances

  • Bone Morphogenetic Protein 2
  • Osteoprotegerin
  • Collagen